# FDA Inspection 708802 - St. Mary's Hospital Corporation/BB - February 08, 2011

Source: https://www.keypedia.com/records/fda_inspections/st-marys-hospital-corporationbb/5942a595-3d2d-4c45-bb00-3a62157fac5d
Source feed: FDA_Inspections

> FDA Inspection 708802 for St. Mary's Hospital Corporation/BB on February 08, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 708802
- Company Name: St. Mary's Hospital Corporation/BB
- Inspection Date: 2011-02-08
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 790061 - 2012-07-10](https://www.keypedia.com/records/fda_inspections/st-marys-hospital-corporationbb/12a61256-bca7-4657-bb0c-513485c86ea8)
- [FDA Inspection 600430 - 2009-07-29](https://www.keypedia.com/records/fda_inspections/st-marys-hospital-corporationbb/84b52a81-d66d-4a70-9987-ec121902a324)

Company: https://www.keypedia.com/companies/st-marys-hospital-corporationbb/57c540ee-49fa-4f8e-a60c-52ecbe755575

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d